H. Döhner

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

H. Döhner, Konstanze Fischer, Martin Bentz et al. · Blood · 1995 · 732 citations · Full text

Medicine, Molecular Biology, Oncology +17

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival

Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger et al. · Haematologica · 2007 · 216 citations · Full text

Life Sciences, Genetics, Oncology +17

Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.

Martin Dreyling, Lars Bullinger, German Ott et al. · PubMed · 1997 · 147 citations

Life Sciences, Molecular Biology, Oncology +17

Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization

Martin Bentz, G Cabot, M Moos et al. · Blood · 1994 · 140 citations · Full text

Medicine, Hematology, Oncology +17

Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia

Guido Marcucci, MA Caligiuri, H. Döhner et al. · Leukemia · 2001 · 119 citations

Medicine, Molecular Biology, Oncology +9